SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maurice Winn who wrote (1454)1/28/1998 12:19:00 AM
From: Roger Cranwill  Read Replies (1) of 1762
 
Maurice-
I got a call today from Annie Hendrichs-she's head of investor relations for IDEC. She's not a member of this site, but has been keeping tabs on what's going on on the board. Also, since she's not a member, she has no way to get in touch with you, so I'm her emissary...She feels you're not getting adequate information from the powers that be, so she'd really like you to e-mail her-she's a great person (had to say that so she'll keep calling me...) Anyway, she'll give you any info you need, just get in touch with her at:
akennedy@idecpharm.com
Also, you might call Genentech's Rituxan Hotline if you have any other questions, at 1-888-777-4464 its a toll-free call in the States, but I don't know how that'll work out from New Zealand. You really touched a lot of people here, and we all wish you and your son the best...Roger
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext